Standout Papers
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group (2008)
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial (2018)
- Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC). (2022)
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer (2010)
- Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023) (2023)
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer (2015)
Immediate Impact
12 by Nobel laureates 8 from Science/Nature 99 standout
Citing Papers
Nanomedicine Tumor Targeting
2024 Standout
Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
2022 Standout
Works of Robert Dreicer being referenced
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert Dreicer | 8323 | 4805 | 2988 | 188 | 12.4k | |
| William Kevin Kelly | 6118 | 3777 | 1854 | 240 | 11.7k | |
| William L. Dahut | 4224 | 5115 | 1206 | 288 | 10.1k | |
| Shahneen Sandhu | 5669 | 5826 | 2464 | 278 | 10.6k | |
| David M. Nanus | 8050 | 4890 | 2485 | 326 | 14.4k | |
| Patricia Troncoso | 7842 | 4342 | 1248 | 250 | 13.5k | |
| Glenn Liu | 4737 | 2771 | 1958 | 172 | 8.3k | |
| Paul N. Mainwaring | 6748 | 2683 | 2353 | 142 | 9.0k | |
| David Olmos | 6034 | 4020 | 1382 | 231 | 10.0k | |
| Eleni Efstathiou | 4556 | 2321 | 1236 | 201 | 7.2k | |
| Amita Patnaik | 4398 | 8248 | 962 | 357 | 14.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...